Chiron Investment Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,749 shares of the healthcare conglomerate's stock, valued at approximately $885,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth $32,000. Institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
Several equities analysts have recently commented on UNH shares. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Truist Financial increased their price objective on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Finally, Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and three have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $632.85.
Get Our Latest Stock Analysis on UNH
UnitedHealth Group Price Performance
Shares of UNH traded down $128.94 during mid-day trading on Friday, hitting $456.10. 29,048,929 shares of the company were exchanged, compared to its average volume of 4,391,399. The stock has a market cap of $417.20 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $438.50 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a 50 day moving average of $514.51 and a 200-day moving average of $541.53.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.